Signaling a move toward the next phase of change, leaders at the National Institutes of Health have sent new guidance to its staff on how to further move its $39 billion portfolio in alignment with the Trump administration’s priorities.
The seven-page guidance, sent on Friday and titled “Reviewing Grants for Priority Alignment,” provides details to program officers, who manage grants within a subject area, on how to determine whether grants fall into the administration’s priorities — and if not, how to appropriately terminate them. The guidance, which follows a public memo from NIH Director Jay Bhattacharya, is another step in the administration’s unprecedented campaign to bend the focus of biomedical research in the country to its will.
Some outside experts said the guidance is a positive step, making future terminations more of a dialogue that researchers can push back on.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in